CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Kauffman Michael Director | Grant or award · Stock Option (right to buy) | +16,078 | 16,078 | ||
| 2024-02-06 | Gagnon Robert E. Director | Sale 10b5-1 | −9,204 | $13.70 | $126K | 27,804 |
| 2024-01-12 | Gagnon Robert E. Director | Sale 10b5-1 | −9,204 | $10.95 | $101K | 37,008 |
| 2024-01-05 | Calkins Daniel Chief Financial Officer | Sale | −6 | $8.50 | $51 | 8,621 |
| 2023-12-26 | Calkins Daniel Chief Financial Officer | Sale | −25 | $8.08 | $202 | 8,350 |
| 2023-12-20 | Calkins Daniel Chief Financial Officer | Sale | −57 | $7.93 | $452 | 8,375 |
| 2023-12-19 | Gagnon Robert E. Director | Sale | −130 | $7.73 | $1K | 46,212 |
| 2023-12-19 | Paterson Dan President and CEO | Sale | −183 | $7.73 | $1K | 86,916 |
| 2023-12-19 | Stuglik Brian M Director | Sale | −274 | $7.73 | $2K | 90,450 |
| 2023-12-18 | Gagnon Robert E. Director | Sale | −284 | $7.64 | $2K | 46,342 |
| 2023-12-18 | Paterson Dan President and CEO | Sale | −244 | $7.64 | $2K | 87,099 |
| 2023-12-18 | Stuglik Brian M Director | Sale | −487 | $7.64 | $4K | 90,724 |
| 2023-10-24 | Calkins Daniel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-10-05 | Calkins Daniel Vice President of Finance | Sale | −5 | $7.30 | $37 | 8,432 |
| 2023-09-25 | Calkins Daniel Vice President of Finance | Sale | −25 | $9.40 | $235 | 8,437 |
| 2023-09-21 | Calkins Daniel Vice President of Finance | Sale | −232 | $9.31 | $2K | 8,462 |
Page 11 of 17 · 326 trades